ADIENNE Pharma & Biotech Signs Service Agreement with Selexis for…

ADIENNE Pharma & Biotech has entered into a Service Agreement with Selexis for the rapid development of a manufacturing cell line for one of ADIENNE’s orphan drugs .

(PRWeb May 15, 2012)

Read the full story at

Comments are closed.

Get email updates

Enter your email address to subscribe to this blog and receive notifications of new posts by email.